Brookdale Senior Living (BKD) Barclays 28th Annual Global Healthcare Conference summary
Event summary combining transcript, slides, and related documents.
Barclays 28th Annual Global Healthcare Conference summary
10 Mar, 2026Leadership and organizational strategy
CEO brings extensive operational experience from military, hospitality, and senior healthcare sectors, emphasizing a shift to an operating-focused model.
Recent hires include a COO and SVP of Strategic Operations to centralize pricing, CapEx, and drive operational excellence.
Regional structure reorganized into six VPO-led teams, with sales and clinical teams now reporting regionally to enhance accountability and execution.
Executive directors are empowered as key leaders, with increased support, training, and accountability.
Leadership is actively engaging with communities and executive directors to foster a more offensive, market-driven culture.
Market dynamics and industry outlook
Demand for senior living is rising as baby boomers age, while new supply remains constrained by high costs and regulatory hurdles.
New construction faces long lead times and higher price points, creating a competitive moat for existing operators.
Current supply-demand imbalance is expected to persist for several years, supporting favorable occupancy trends.
New entrants target higher price segments, reducing direct competition for existing communities.
Operational performance and occupancy trends
Multi-year guidance targets mid-teens adjusted EBITDA growth, leveraging market-level strategies and operational excellence.
Occupancy reached 82.1% in February, up 280 bps year-over-year, with recent sequential declines attributed to seasonality and weather disruptions.
Centralized pricing and analytics enable targeted rate actions by unit and care type, optimizing occupancy and revenue.
Rate increases have led to slight upticks in move-outs, but overall economics remain positive.
Latest events from Brookdale Senior Living
- Record 2025 EBITDA and occupancy set stage for robust 2026 growth and portfolio streamlining.BKD
Q4 202519 Feb 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Accelerating occupancy, strong cash flow, and innovation position for sustained growth.BKD
Barclays 27th Annual Global Healthcare Conference26 Dec 2025 - 2024 results beat guidance; 2025 targets 11%-15% EBITDA growth and positive cash flow.BKD
Q4 202415 Dec 2025 - Contested director election, performance-based pay, and auditor ratification headline the 2025 proxy.BKD
Proxy Filing1 Dec 2025 - Ortelius seeks to overhaul board leadership to address underperformance and drive value creation.BKD
Proxy Filing1 Dec 2025